fiacitabine has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, D; Fox, JJ; Leyland-Jones, B; Lopez, C; Philips, FS; Schneider, R; Tan, CT; Watanabe, KA; Young, CW | 1 |
| Cheng, YC; Dutschman, G; Ruth, JL; Tan, RS | 1 |
| Donnelly, H; Donner, AL; Fanucchi, M; Fox, J; Groshen, S; Leyland-Jones, B; Myskowski, P | 1 |
1 trial(s) available for fiacitabine and Neoplasms
| Article | Year |
|---|---|
2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemical Phenomena; Chemistry; Child; Clinical Trials as Topic; Cytarabine; Double-Blind Method; Female; Herpes Zoster; Humans; Immune Tolerance; Male; Middle Aged; Nausea; Neoplasms; Random Allocation; Vidarabine; Vomiting | 1986 |
2 other study(ies) available for fiacitabine and Neoplasms
| Article | Year |
|---|---|
Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection.
Topics: Antiviral Agents; Cytarabine; Drug Evaluation; Hematopoiesis; Herpesviridae Infections; Humans; Immunosuppression Therapy; Neoplasms | 1983 |
Cytotoxicity of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine and its relationship to deoxycytidine deaminase.
Topics: Antineoplastic Agents; Cytarabine; DCMP Deaminase; Deoxycytidine Kinase; Humans; Neoplasms; Nucleotide Deaminases; Structure-Activity Relationship; Thymidine Kinase | 1983 |